Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127610721 | 12761072 | 1 | I | 20160905 | 20160916 | 20160920 | 20160920 | EXP | GB-MHRA-EYC 00145179 | GB-UCBSA-2016035800 | UCB | 60.00 | YR | F | Y | 90.00000 | KG | 20160920 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127610721 | 12761072 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | Oral | 100 MG, ONCE DAILY (QD) | 87900 | MG | U | 21035 | 100 | MG | QD | ||||
| 127610721 | 12761072 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | 25 MG, WEEKLY (QW) | U | 0 | 25 | MG | /wk | ||||||
| 127610721 | 12761072 | 3 | C | BUPRENORPHINE. | BUPRENORPHINE | 1 | UNK | U | 0 | ||||||||||
| 127610721 | 12761072 | 4 | C | Colecalciferol | CHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
| 127610721 | 12761072 | 5 | C | Ferrous fumarate | FERROUS FUMARATE | 1 | UNK | U | 0 | ||||||||||
| 127610721 | 12761072 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | U | 0 | ||||||||||
| 127610721 | 12761072 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 127610721 | 12761072 | 8 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127610721 | 12761072 | 1 | Partial seizures |
| 127610721 | 12761072 | 2 | Rheumatoid arthritis |
| 127610721 | 12761072 | 3 | Product used for unknown indication |
| 127610721 | 12761072 | 4 | Product used for unknown indication |
| 127610721 | 12761072 | 5 | Product used for unknown indication |
| 127610721 | 12761072 | 6 | Product used for unknown indication |
| 127610721 | 12761072 | 7 | Product used for unknown indication |
| 127610721 | 12761072 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127610721 | 12761072 | OT |
| 127610721 | 12761072 | LT |
| 127610721 | 12761072 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127610721 | 12761072 | Dizziness | |
| 127610721 | 12761072 | Neutropenic sepsis | |
| 127610721 | 12761072 | Pancytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127610721 | 12761072 | 1 | 20140411 | 20160905 | 0 | |
| 127610721 | 12761072 | 2 | 20131101 | 20160905 | 0 |